Many halogenated compounds are used as intermediates in the synthesis of compounds of interest to the chemical, pharmaceutical industries; however, chemical halogenation involves the use of high-cost reagents that are often harmful to the environment.
Electrochemical methods like electrocoagulation (EC) can remove a vast array of compounds from wastewater but are not ideal for emerging pollutants found at low concentrations (ng/L to μg/L). In contrast, enzymes are known to effectively target these pollutants, but their performance can be hindered in complex water matrices. This work explores a biocatalytic treatment assisted by electrochemical processes to remove two emerging pollutants, Bisphenol A (BPA) and Triclosan (TCS) from municipal wastewater.
Use of lignocellulosic biomass in continuous processes in biorefineries poses challenges due to its recalcitrant properties, feedstock variability, and materials handling of solids at large scale. Limitations include lignin derived inhibitors, and resistance to mixing due to rheological properties of lignocellulosic particulates at high solids loadings.
Traditional methods of oxidizing alcohols often rely on toxic reagents, as well as high pressures and temperatures, which can be hazardous. In contrast, biocatalysis utilizes enzymes as natural and non-toxic catalysts, typically under milder reaction conditions. This study aims to perform oxidation reactions of primary and secondary alcohols using enzymes as catalysts.
Ginkgo Bioworks is a platform for cell programming, offering comprehensive, end-to-end services that address complex challenges across various industries, including food and agriculture, pharmaceuticals, and industrial chemicals. The company specializes in enzyme engineering, providing tailored solutions such as biocatalysts that replace traditional chemical synthesis steps, enhance enzyme functionality, and reduce manufacturing costs at scale. These innovations empower clients to optimize their R&D projects and improve overall efficiency.
Key points
The Biocatalysis Guide is a simple double-sided, single-sheet guide to the currently most used enzyme classes amongst the ACS GCI Pharmaceutical Roundtable member companies. It has been produced to be an easy to follow guide for chemists who have not had significant exposure to biocatalysis, showing generic transformations that are available so these can be factored into retrosynthetic analysis. In order to keep the sheet easy to read it is not an exhaustive guide to every transformation and it does not carry literature references.
Creates products through technologies derived from yeast production and focuses on yeast-related biotechnology applications and research. Oriental Yeast Company produces recombinant enzymes, recombinant human proteins, coenzymes, and substrates to improve crop yields, develop vaccines, and also offer customized dough improvers. Customizing dough for each client allows clients to maximize food quality while lowering costs and ingredient waste. Some of Oriental Yeast Company's coenzymes are used in manufacturing of Active Pharmaceutical Ingredients (API) through biocatalysis.